Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy

According to a report by MarketWatch… The drugmaker, best known for developing weight-loss and diabetes drugs, failed to excite investors hoping for a turnaround. complete report is on link below: Source: https://www.marketwatch.com/story/novo-nordisk-stock-tumbles-as-ozempic-maker-sets-out-2030-goals-8a5a8d2d?mod=mw_rss_topstories